David Hardten on CTAK
October 16, 2023
Keratoconus is a very frustrating disease with visual disability often requiring a corneal transplant when vision degrades to where glasses or contacts don’t work well. CTAK corneal tissue addition provides a great option for those patients with quick recovery, improved vision without the long recovery or risk of a corneal transplant. We’ve been very happy with the results.
Recent Articles
-
Bernie’s Quartely – November 2023
A message from Bernie Iliakis, President & CEO of CorneaGen...
READ MORE -
Annie Thompson Recognized by Fabulous Washington
Our very own CFO, Annie Thompson, has been profiled in...
READ MORE -
Bernie’s Quarterly Update – June 2023
We’re halfway through 2023 and happy about how things are...
READ MORE -
CorneaGen Recognized With Cigna Healthy Workforce Designation
Cigna has selected CorneaGen as a recipient of their Bronze...
READ MORE